With aging of the Hong Kong population, osteoporosis has become one of the most prevalent conditions that is associated with great medical and socioeconomic burden. In view of rapid advancement in the diagnosis and treatment of the disease in the past few years, the Osteoporosis Society of Hong Kong feels the need to update the management guidelines currently available in Hong Kong. This present set of guidelines highlights the current consensus in the diagnosis and management of osteoporosis. An evidence-based account on the pharmacological treatment of osteoporosis is given. Reference is also drawn to available published data collected from local sources. These guidelines aim to provide a basis for the management of osteoporosis for the practising physicians in Hong Kong.
